Pyraziner
Filtrerede søgeresultater
6-Biopterin, MedChemExpress
MedChemExpress 6-Biopterin (L-Biopterin), a pterin derivative, is a NO synthase cofactor.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | 6-Biopterin |
|---|---|
| Sundhedsfare 1 | H315∣H319∣H335 |
| Formel vægt | 237.22 |
| Opløselighedsinformation | DMSO : 12.5 mg/mL (52.69 mM; ultrasonic and warming and heat to 75°C) |
| Procent renhed | 97.0% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 237.22 |
| CAS | 22150-76-1 |
| Synonym | L-Biopterin |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | O=C1N=C(N)NC2=NC=C([C@@H](O)[C@@H](O)C)N=C12 |
| Renhedsgrad noter | Research |
| Molekylær formel | C9H11N5O3 |
| Til brug med (applikation) | Cancer-programmed cell death |
EIPA, MedChemExpress
MedChemExpress EIPA (L593754) is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3). EIPA inhibits macropinocytosis as well. EIPA can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | EIPA |
|---|---|
| Sundhedsfare 1 | H315∣H319∣H335 |
| Formel vægt | 299.76 |
| Opløselighedsinformation | DMSO : 140 mg/mL (467.04 mM; Need ultrasonic) |
| Procent renhed | 98.0% |
| Fysisk form | Solid |
| Farve | Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 299.76 |
| CAS | 1154-25-2 |
| Synonym | L593754 MH 12-43 |
| Holdbarhed | Powder -20°C 3 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=NC(Cl)=C(N(CC)C(C)C)N=C1N)NC(N)=N |
| Renhedsgrad noter | Research |
| Molekylær formel | C11H18ClN7O |
| Til brug med (applikation) | Cancer-programmed cell death |
HSR6071, MedChemExpress
MedChemExpress HSR6071, a pyrazinecarboxamide derivative, is an orally active and potent antiallergic agent. HSR6071 potently inhibits the experimental asthma in rat models.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | HSR6071 |
|---|---|
| Formel vægt | 260.26 |
| Opløselighedsinformation | H2O : 50 mg/mL (192.12 mM; ultrasonic and adjust pH to 12 with NaOH) |
| Procent renhed | 98.51% |
| Fysisk form | Powder |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 260.26 |
| CAS | 111374-21-1 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=NC(N2CCCC2)=CN=C1)NC3=NN=NN3 |
| Renhedsgrad noter | Research |
| Molekylær formel | C10H12N8O |
| Til brug med (applikation) | COVID-19-immunoregulation |
AZD7687, MedChemExpress
MedChemExpress AZD7687 is a potent, selective, reversible and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor with an IC50 of 80 nM for human DGAT1. AZD7687 can be used for type 2 diabetes mellitus and obesity research.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | AZD7687 |
|---|---|
| Formel vægt | 367.44 |
| Opløselighedsinformation | DMSO : ≥ 50 mg/mL (136.08 mM) |
| Procent renhed | 99.04% |
| Fysisk form | Solid |
| Farve | Pink |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 367.44 |
| CAS | 1166827-44-6 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | CC1=C(C(N)=O)N=C(C2=CC=C([C@H]3CC[C@H](CC(O)=O)CC3)C=C2)C(C)=N1 |
| Renhedsgrad noter | Research |
| Molekylær formel | C21H25N3O3 |
| Til brug med (applikation) | Metabolism-sugar/lipid metabolism |
5-(N,N-Hexamethylene)-amiloride, MedChemExpress
MedChemExpress 5-(N,N-Hexamethylene)-amiloride (Hexamethylene amiloride) derives from an amiloride and is a potent Na+/H+ exchanger inhibitor, which decreases the intracellular pH (pHi) and induces apoptosis in leukemic cells.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | 5-(N,N-Hexamethylene)-amiloride |
|---|---|
| Formel vægt | 311.77 |
| Opløselighedsinformation | DMSO : 100 mg/mL (320.75 mM; Need ultrasonic) |
| Procent renhed | 98.0% |
| Fysisk form | Powder |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 311.77 |
| CAS | 1428-95-1 |
| Synonym | Hexamethylene amiloride HMA |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=NC(Cl)=C(N2CCCCCC2)N=C1N)NC(N)=N |
| Renhedsgrad noter | Research |
| Molekylær formel | C12H18ClN7O |
| Til brug med (applikation) | Cancer-programmed cell death |
BG45, MedChemExpress
MedChemExpress BG45 is an HDAC class I inhibitor with selectivity for HDAC3 (IC50 = 289 nM).
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | BG45 |
|---|---|
| Sundhedsfare 1 | H302∣H315∣H319∣H335 |
| Formel vægt | 214.22 |
| Opløselighedsinformation | DMSO : ≥ 48 mg/mL (224.07 mM) |
| Procent renhed | 99.95% |
| Fysisk form | Solid |
| Farve | Yellow |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 214.22 |
| CAS | 926259-99-6 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=NC=CN=C1)NC2=CC=CC=C2N |
| Renhedsgrad noter | Research |
| Molekylær formel | C11H10N4O |
| Til brug med (applikation) | Cancer-programmed cell death |
Acipimox, MedChemExpress
MedChemExpress Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Acipimox |
|---|---|
| Formel vægt | 154.12 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (648.85 mM) ∣H2O : 20 mg/mL (129.77 mM; Need ultrasonic) |
| Procent renhed | 99.0% |
| Fysisk form | Solid |
| Farve | Off-White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 154.12 |
| CAS | 51037-30-0 |
| Synonym | K-9321 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(C1=C[N+]([O-])=C(C)C=N1)O |
| Renhedsgrad noter | Research |
| Molekylær formel | C6H6N2O3 |
| Til brug med (applikation) | COVID-19-immunoregulation |
Caficrestat, MedChemExpress
MedChemExpress Caficrestat (Aldose reductase-IN-1) is a inhibitor of aldose reductase with IC50 of 28.9 pM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Caficrestat |
|---|---|
| Formel vægt | 421.35 |
| Opløselighedsinformation | DMSO : ≥ 28 mg/mL (66.45 mM) |
| Procent renhed | 99.88% |
| Fysisk form | Solid |
| Farve | White |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 421.35 |
| CAS | 1355612-71-3 |
| Synonym | Aldose reductase-IN-1 AT-001 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C1C2=NC=CN=C2C(CC(O)=O)=NN1CC3=NC4=C(C=CC(C(F)(F)F)=C4)S3 |
| Renhedsgrad noter | Research |
| Molekylær formel | C17H10F3N5O3S |
| Til brug med (applikation) | Metabolism-sugar/lipid metabolism |
VE-821, MedChemExpress
MedChemExpress VE-821 is a potent ATP-competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | VE-821 |
|---|---|
| Formel vægt | 368.41 |
| Opløselighedsinformation | DMSO : 50 mg/mL (135.72 mM; Need ultrasonic) ∣H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble) |
| Procent renhed | 98.94% |
| Fysisk form | Solid |
| Farve | Green |
| Grad | Research |
| Anbefalet opbevaring | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| Molekylvægt (g/mol) | 368.41 |
| CAS | 1232410-49-9 |
| Holdbarhed | Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month |
| SMIL | O=C(NC1=CC=CC=C1)C2=NC(C3=CC=C(C=C3)S(=O)(C)=O)=CN=C2N |
| Renhedsgrad noter | Research |
| Molekylær formel | C18H16N4O3S |
| Til brug med (applikation) | Cancer-Kinase/protease |
Amiloride hydrochloride, MedChemExpress
MedChemExpress Amiloride hydrochloride (MK-870 hydrochloride) is an inhibitor of both epithelial sodium channel (ENaC) and urokinase-type plasminogen activator receptor (uTPA). Amiloride hydrochloride is a blocker of polycystin-2 (PC2; TRPP2) channel.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Amiloride hydrochloride |
|---|---|
| Formel vægt | 266.09 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (375.81 mM) ∣H2O : 7.14 mg/mL (26.83 mM; Need ultrasonic) |
| Procent renhed | 99.46% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 266.09 |
| CAS | 2016-88-8 |
| Synonym | MK-870 hydrochloride |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | O=C(C1=NC(Cl)=C(N)N=C1N)NC(N)=N.Cl |
| Renhedsgrad noter | Research |
| Molekylær formel | C6H9Cl2N7O |
| Til brug med (applikation) | Metabolism-protein/nucleotide metabolism |
Naquotinib mesylate, MedChemExpress
MedChemExpress Naquotinib mesylate (ASP8273 mesylate) is an orally available, mutant-selective and irreversible EGFR inhibitor; with IC50s of 8-33 nM toward EGFR mutants and 230 nM for EGFR.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Naquotinib mesylate |
|---|---|
| Formel vægt | 658.81 |
| Opløselighedsinformation | DMSO : 12.5 mg/mL (18.97 mM; Need ultrasonic and warming) |
| Procent renhed | 98.02% |
| Fysisk form | Solid |
| Farve | Yellow |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 658.81 |
| CAS | 1448237-05-5 |
| Synonym | ASP8273 (mesylate) |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | O=C(C1=NC(CC)=C(O[C@H]2CN(C(C=C)=O)CC2)N=C1NC3=CC=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)N.CS(=O)(O)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C31H46N8O6S |
| Til brug med (applikation) | Cancer-Kinase/protease |
Gilteritinib, MedChemExpress
MedChemExpress Gilteritinib (ASP2215) is a potent and ATP-competitive FLT3/AXL inhibitor with IC50s of 0.29 nM/0.73 nM, respectively.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Gilteritinib |
|---|---|
| Formel vægt | 552.71 |
| Opløselighedsinformation | Ethanol : 100 mg/mL (180.93 mM; ultrasonic and adjust pH to 2 with HCl) ∣DMSO : 2 mg/mL (3.62 mM; Need ultrasonic) |
| Procent renhed | 97.77% |
| Fysisk form | Solid |
| Farve | Light Yellow |
| Grad | Research |
| Anbefalet opbevaring | 4°C, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (stored under nitrogen) |
| Molekylvægt (g/mol) | 552.71 |
| CAS | 1254053-43-4 |
| Synonym | ASP2215 |
| Holdbarhed | 4°C, stored under nitrogen∣In solvent : -80°C, 6 months∣-20°C, 1 month (stored under nitrogen) |
| SMIL | NC(C1=NC(CC)=C(NC2CCOCC2)N=C1NC3=CC(OC)=C(N4CCC(N5CCN(C)CC5)CC4)C=C3)=O |
| Renhedsgrad noter | Research |
| Molekylær formel | C29H44N8O3 |
| Til brug med (applikation) | Cancer-Kinase/protease |
EIPA hydrochloride, MedChemExpress
MedChemExpress EIPA (L593754) hydrochloride is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA hydrochloride also enhances autophagy by inhibiting Na+/H+-exchanger 3 (NHE3). EIPA hydrochloride inhibits macropinocytosis as well. EIPA hydrochloride can be used in the research of inflammation and cancers, such as gastric cancer, colon carcinoma, pancreatic carcinoma.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | EIPA hydrochloride |
|---|---|
| Formel vægt | 336.22 |
| Opløselighedsinformation | DMSO : 130 mg/mL (386.65 mM; Need ultrasonic) |
| Procent renhed | 99.92% |
| Fysisk form | Solid |
| Farve | Yellow |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 336.22 |
| CAS | 1345839-28-2 |
| Synonym | L593754 hydrochloride MH 12-43 hydrochloride |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | O=C(C1=NC(Cl)=C(N(CC)C(C)C)N=C1N)NC(N)=N.Cl |
| Renhedsgrad noter | Research |
| Molekylær formel | C11H19Cl2N7O |
| Til brug med (applikation) | Neuroscience-Neuromodulation |
Benzamil hydrochloride, MedChemExpress
MedChemExpress Benzamil hydrochloride (Benzylamiloride hydrochloride), an Amiloride analogue, is a Na+/Ca2+ exchanger (NCX) inhibitor (IC50∼100 nM). Benzamil hydrochloride also is a non-selective Deg/epithelial sodium channels (ENaC) blocker, and can potentiate myogenic vasoconstriction. Benzamil hydrochloride inhibits TRPP3-mediated Ca2+-activated currents, with an IC50 of 1.1 μM.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Kemisk navn eller materiale | Benzamil hydrochloride |
|---|---|
| Sundhedsfare 1 | H315∣H319∣H335 |
| Formel vægt | 356.21 |
| Opløselighedsinformation | DMSO : ≥ 100 mg/mL (280.73 mM) ∣H2O : < 0.1 mg/mL (insoluble) |
| Procent renhed | 99.6% |
| Fysisk form | Solid |
| Farve | Yellow |
| Grad | Research |
| Anbefalet opbevaring | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| Molekylvægt (g/mol) | 356.21 |
| CAS | 161804-20-2 |
| Synonym | Benzylamiloride hydrochloride |
| Holdbarhed | 4°C, sealed storage, away from moisture∣In solvent : -80°C, 6 months∣-20°C, 1 month (sealed storage, away from moisture) |
| SMIL | O=C(C1=NC(Cl)=C(N)N=C1N)NC(NCC2=CC=CC=C2)=N.[H]Cl |
| Renhedsgrad noter | Research |
| Molekylær formel | C13H15Cl2N7O |
| Til brug med (applikation) | COVID-19-immunoregulation |
Amiloride hydrochloride dihydrate, MedChemExpress
MedChemExpress Amiloride hydrochloride dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC) and urokinase-type plasminogen activator receptor (uTPA). Amiloride hydrochloride dihydrate is a blocker of polycystin-2 (PC2; TRPP2) channel.
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More